Other Liabilities

3 Months Ended

Jun. 30, 2021

Other Liabilities Disclosure [Abstract]

Certain Balance Sheet Components

Certain Balance Sheet Components

Cash, Cash Equivalents and Restricted Cash

Cash as reported on the unaudited condensed consolidated statements of cash flows includes the aggregate amounts of cash, cash equivalents, and restricted cash and consists of the following (in thousands):

	June 30,
	2021		2020
Cash and cash equivalents	$	484,960	$	84,726
Restricted cash	9,087		1,374
Total cash, cash equivalents and restricted cash	$	494,047	$	86,100

Cash and cash equivalents include cash deposits in banks and all highly liquid investments that are readily convertible to cash (maturity of three months or less at the time of purchase). Restricted cash consists of funds held or designated to satisfy the requirements of certain agreements that are restricted in their use and are included in other assets on the unaudited condensed consolidated balance sheets. As of June 30, 2021 and March 31, 2021, restricted cash includes approximately $7.1 million and $1.0 million, respectively, that is held in an escrow fund for use by Sunovion Pharmaceuticals Inc. (“Sunovion”), a subsidiary of Sumitomo Dainippon Pharma, to manage rebates, chargebacks, and similar fees pursuant to the Market Access Services Agreement (see Note 5(C)).

Inventory

As of June 30, 2021 and March 31, 2021, inventory consisted of the following (in thousands):

	June 30, 2021		March 31, 2021
Raw materials	$	1,321	$	1,390
Work in process	1,883		773
Finished goods	968		448
Total inventory	$	4,172	$	2,611

Accrued Expenses and Other Current Liabilities

As of June 30, 2021 and March 31, 2021, accrued expenses and other current liabilities consisted of the following (in thousands):

	June 30, 2021		March 31, 2021
Accrued R&D expenses	$	7,894	$	8,544
Accrued compensation-related expenses	17,936		20,571
Accrued commercial expenses	8,065		7,770
Accrued sales discounts, rebates, and allowances	4,737		1,315
Deferred net product revenue	—		162
Accrued professional service fees	1,075		935
Accrued other expenses and tax obligations	3,231		5,315
Total accrued expenses and other current liabilities	$	42,938	$	44,612